Name: Dual specificity protein kinase CLK2 Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Dual specificity protein kinase CLK2 Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	4-[[4-Cyclopentyloxy-5-(2-methyl-1,3-benzoxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-methoxy-N-methylbenzamide	IC50	6.0 ^[1], 15.0 ^[2], 549.0 ^[3]
	Silmitasertib	IC50	3.8 ^[1]
	9H-Purine-2,6-diamine, N2-(2-aminocyclohexyl)-N6-(3-chlorophenyl)-9-ethyl-, cis-	IC50	111.0 ^[1]
	CID 53246941	IC50	112.0 ^[1]
	6-(1,3-Benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine	IC50	1902.0 ^[1]
Rows per page: 1–5 of 100

References

This online resource may be cited as follows

MLA	"Quest Database™ Dual specificity protein kinase CLK2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 28 Dec. 2025, https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk2-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 28). Quest Database™ Dual specificity protein kinase CLK2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk2-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan